(Q45168757)

English

Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome

scientific article published in February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 December 2017

Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome (English)

1 reference

Europe PubMed Central

10 December 2017

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

author name string

Marlene Roa Barrios

1

1 reference

Europe PubMed Central

10 December 2017

Gabriela Arata-Bellabarba

2

1 reference

Europe PubMed Central

10 December 2017

Lenin Valeri

3

1 reference

Europe PubMed Central

10 December 2017

Elsy Velázquez-Maldonado

4

1 reference

Europe PubMed Central

10 December 2017

publication date

1 February 2009

1 reference

Europe PubMed Central

10 December 2017

Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion

1 reference

Europe PubMed Central

10 December 2017

56

1 reference

Europe PubMed Central

10 December 2017

2

1 reference

Europe PubMed Central

10 December 2017

59-65

1 reference

Europe PubMed Central

10 December 2017

Polycystic ovary syndrome: a changing perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension. Parallels between human disease and rodent models

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Dyslipidemia of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

LDL-cholesterol, HDL-cholesterol or triglycerides--which is the culprit?

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Postprandial triglyceride response in patients with polycystic ovary syndrome: relationship with waist-to-hip ratio and insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Smaller LDL particle size in women with polycystic ovary syndrome compared to controls

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipid and lipoprotein profile in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)).

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The metabolic syndrome--a new worldwide definition

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Polycystic ovary syndrome: syndrome XX?

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin resistance and sympathetic overactivity in women

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2970553-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1575-0922(09)70553-4

1 reference

Europe PubMed Central

10 December 2017

1 reference

Europe PubMed Central

10 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45168757&oldid=2068830366"